The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease.

MLA

Decramer, Marc L., et al. “The Safety of Long-Acting SS2-Agonists in the Treatment of Stable Chronic Obstructive Pulmonary Disease.” International Journal of COPD, vol. 8, Jan. 2013, pp. 53–64. EBSCOhost, https://doi.org/10.2147/COPD.S39018.

APA

Decramer, M. L., Hanania, N. A., Lötvall, J. O., & Yawn, B. P. (2013). The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease. International Journal of COPD, 8, 53–64. https://doi.org/10.2147/COPD.S39018

Chicago

Decramer, Marc L., Nicola A. Hanania, Jan O. Lötvall, and Barbara P. Yawn. 2013. “The Safety of Long-Acting SS2-Agonists in the Treatment of Stable Chronic Obstructive Pulmonary Disease.” International Journal of COPD 8 (January): 53–64. doi:10.2147/COPD.S39018.